atai Fellowship Fund in Psychedelic Neuroscience
Email: SREIS@mgh.harvard.edu
Overview
The atai Fellowship Fund in Psychedelic Neuroscience, established through the generous support of atai Life Sciences (now AtaiBeckley), supports early-career researchers investigating the fundamental mechanisms of action and therapeutic potential of psychedelic compounds and other modulators of neuroplasticity.
Based at the Massachusetts General Hospital Center for the Neuroscience of Psychedelics, the fellowship provides graduate students, postdoctoral researchers, and other trainees with funding, mentorship, and opportunities for interdisciplinary collaboration. Fellows work with investigators across neuroscience, psychiatry, chemical biology, neuroimaging, and related fields, pursuing innovative research that bridges fundamental discovery and clinical applications.
The fellowship supports a broad range of research, including the molecular and cellular mechanisms of psychedelic action, neuroplasticity, novel therapeutic compounds, neuroimaging, and clinical applications of psychedelic-assisted therapy. In addition to advancing scientific discovery, the program seeks to cultivate the next generation of investigators in psychedelic neuroscience and medicine.
Current Fellows
- Grant Jones, PhD — Psychedelic Use, Mental Health Outcomes, and Suicidality
- Karis Will — Investigating the Endogenous Biosynthesis of N,N-Dimethyltryptamine (DMT) in the Human Brain
- Sergio Lázaro Martínez — Neuroethnopharmacological Investigation of Psychoactive Plants and Their Neuromodulatory Mechanisms
- Arthur “AJ” Schick III — Psychedelics Tryptamines and the Potential Role of Sigma-1 Receptor Signaling in Headache Treatments
- Hosein Yazdanpanah, MD — Wearable Technologies for Monitoring Physiological Changes Associated with Psychedelic-Assisted Therapy
Former Fellows
- Erin Mauney, MD — Neuroimaging Correlates of Visceral Pain Before and After Psilocybin-Assisted Therapy for Irritable Bowel Syndrome
- Charlotte Schiewe — Mechanisms of Psychedelic Therapeutic Effects and Individual Differences in Treatment Response
- Clare Shaffer — Multimodal Predictions and Mechanisms of Psychedelics in Depression
- Acile Nahlawi, MD — Echocardiographic Assessment of Cardiac Structure and Function in Psychedelic Users